Reaction
Respiratory Tract Infection Fungal reporting signals
As of the last recalculation, Respiratory Tract Infection Fungal appears in 524 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 55.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Basiliximab | 16 | 55.7 | 55.8 |
| Busulfan | 20 | 52.5 | 52.5 |
| Itraconazole | 14 | 48.9 | 49.0 |
| Voriconazole Injection | 25 | 48.0 | 48.0 |
| Piperacillin And Tazobactam | 14 | 44.6 | 44.7 |
| Amikacin | 18 | 43.4 | 43.4 |
| Posaconazole Delayed-Release | 11 | 40.6 | 40.7 |
| Posaconazole | 16 | 40.3 | 40.4 |
| Ganciclovir | 10 | 39.5 | 39.6 |
| Amphotericin B | 12 | 38.9 | 38.9 |
| Ganciclovir Sodium | 10 | 38.2 | 38.3 |
| Voriconazole | 26 | 35.7 | 35.8 |
| Piperacillin Sodium And Tazobactam Sodium | 16 | 33.4 | 33.4 |
| Pegaspargase | 10 | 33.1 | 33.1 |
| Piperacillin Sodium,Tazobactam Sodium | 20 | 31.1 | 31.1 |
| Valganciclovir Hydrochloride Powder, | 9 | 29.8 | 29.8 |
| Thiotepa | 7 | 29.5 | 29.5 |
| Cytarabine | 38 | 27.0 | 27.0 |
| Fludarabine Phosphate | 24 | 25.4 | 25.4 |
| Cladribine | 6 | 25.1 | 25.1 |
| Dornase Alfa | 7 | 14.4 | 14.4 |